STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT06734221

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06734221
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06734221. Allocation not applicable; no masking; primary purpose treatment. Start 2024-09-15 (actual); primary completion 2026-09-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions
Acronym
STAR-PAK
Condition
Popliteal Artery Stenosis Above the Knee
Condition
Peripheral Artery Disease
Condition
Superficial Femoral Artery Stenosis
Intervention (Device)
Paclitaxel Coated Peripheral Angioplasty Balloon Catheter
Lead sponsor
Balton Sp.zo.o. (class: industry)
Collaborator
KCRI (class: other)

Record details

Record id
cardio:ct-nct06734221
Content hash
c885f57aada8b9c2d403fcaad9dc3c326a7e2ca1d54cae866c5e69f621ab894c